Yin-Yin Wang works within Pfizer's US Medical Affairs organization, focusing on how AI can improve the way medical teams engage with HCPs and measure the impact of those efforts across the drug lifecycle. She has spent over a decade in biopharma and management consulting, building experience across drug development, launch excellence, and digital health. She holds a PhD in Microbiology and Immunology from the University of Rochester.
AI is rapidly entering launch planning, but many teams are still working out where it meaningfully improves speed, quality and decision-making. Across medical, commercial, access, analytics and field teams, the opportunity is not just automation, it is using AI to improve insight generation, content development, stakeholder engagement and launch execution without losing rigour, compliance or human judgment. Attend this session to delve into a range of perspectives on:
• Identifying where AI can reduce launch workload and accelerate readiness
• Applying AI to insight synthesis, content development and customer engagement
• Balancing speed, compliance and quality in AI-enabled launch workflows
• Supporting leaner teams while maintaining launch performance and impact
Check out the incredible speaker line-up to see who will be joining Yin-Yin.
Download The Latest Agenda